Full Year 2021 SanBio Co Ltd Earnings Call Transcript
Hello. This is Keita Mori from SanBio. We are now going to start the financial results update for the fiscal year ending January 31, 2021. First, actually, we just reached our 20th anniversary last month, February of this year. From 20 years ago, we have been trying to create new categories of medicine, and all of us at SanBio has been working hard and diligently to fulfill this goal. It feels like the time has passed very quickly as we have been working in this mission. Today is the first meeting since the 20th anniversary, and we are delighted to provide the snapshot of where we are as of today.
As usual, I'd like to provide updates on the financial results. First, income statement. Our operating expense were in line with the previous year, as you can see. And operating expense are staying at around $55 million, $60 million equivalent this year as well. I'd like to just highlight that this year, we have sold our holdings of our investment securities, namely CareNet, and that -- due to this,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
